Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06302595 · ClinicalTrials.gov registry record · NA
MRI Guided Prostate Biopsy
A NA study of Suspected Prostate Cancer, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06302595: Recruiting NA study of Suspected Prostate Cancer, sponsored by Brigham and Women's Hospital.
NCT06302595 is a NA study of Suspected Prostate Cancer that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06302595, a NA study of Suspected Prostate Cancer, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the feasibility of magnetic resonance (MR) guided prostate biopsy using a needle holder frame. This frame is used to help position the needle used for the biopsy. The feasibility in this study is defined as whether the needle holder frame enables accurate tissue sampling from a suspicious region in the prostate found on an MR image. If it does, a biopsy can be carried out with the needle holder frame safely in a clinical routine. The study will be conducted during a routine MR-guided prostate biopsy procedure with an investigational needle holder frame instead of a conventional needle-guiding template.
Primary Outcome
The number of biopsy failures (defined as the number of needle insertions that miss the target zone defined on MRI).
Conditions Studied
Interventions
- DEVICE MRI-guided prostate biopsy using the needle holder frame.
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-08-24 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06302595 shows while recruiting
NCT06302595 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Suspected Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI-guided prostate biopsy using the needle holder frame. is the first listed.
NCT06302595 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06302595 about?
NCT06302595 is a clinical study titled "MRI Guided Prostate Biopsy". This study aims to assess the feasibility of magnetic resonance (MR) guided prostate biopsy using a needle holder frame. This frame is used to help position the needle used for the biopsy. The feasibility in this study is defined as whether the needle holder frame enables accurate tissue sampling fr...
What is the current status of trial NCT06302595?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2023-08-24. Estimated completion is 2026-06.
What conditions does trial NCT06302595 study?
This clinical trial studies the following conditions: Suspected Prostate Cancer.
What interventions are being tested in trial NCT06302595?
The interventions under investigation include: MRI-guided prostate biopsy using the needle holder frame. (DEVICE).
Who is sponsoring clinical trial NCT06302595?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06302595 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06302595's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI